Fig. 4
From: Inhibiting corneal transplantation rejection via lymphatic vessel ligation in a novel murine model
Neovascularisation and lymphangiogenesis images (A–D). (A) CD31 (blood vessels) and (B) LYVE-1 (lymphatic vessels) staining of the cornea exhibiting rejection in the control group. (C) CD31 and (D) LYVE-1 staining of the cornea without rejection in the ligation/Ag group. (E) The graph shows a comparison of the percent area of CD31 staining among the groups. (F) The graph represents a comparison of the percent area of LYVE-1 staining among the groups. * p < 0.05, **p < 0.01, *** p < 0.0001.
